Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
At Stanford we offer a full spectrum of the most up to date and advanced therapies for all stages of Hodgkin's lymphoma, including treatment for relapsed disease. Standard treatment depends on the stage of disease and consists of chemotherapy alone, a combination of chemotherapy and radiation therapy (combined modality therapy), or raditaion therapy alone. Our focus is on using regimens that achieve a high cure rate, preserve fertility, and minimize late effects.
Types of treatment for Hodgkin's lymphoma include:
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.